Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.313NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.402NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.609NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.344NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.556NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.245NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.403NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.636NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.126NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.1.47NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQ.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JD.1.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBC.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.31.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GK.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.27NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.2.3.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FD.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.44NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.26NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GN.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FW.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.1.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BL.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.59NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BR.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BQ.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CM.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CN.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.2.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BG.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BF.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.4.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.576NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.325NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.22NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.521NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.378NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.206NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.28NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.77NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HK.13.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HV.1.9NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used